SARS-CoV-2 and the spike protein in endotheliopathy

Margherita Rosati, Mahesh Agarwal, Xintao Hu, Santhi Devasundaram, Dimitris Stellas, Bhabadeb Chowdhury, Jenifer Bear, Robert Burns, Duncan Donohue, Laurent Pessaint, Hanné Andersen, Mark G. Lewis, Evangelos Terpos, Meletios A Dimopoulos, Alexander Wlodawer, James I. Mullins, David Venzon,

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/j.tim.2023.06.004
Year: 2023
Published: —
Language: en

Article Details

Volume: 32
Issue: 1
Link Of The Paper: https://doi.org/10.1016/j.tim.2023.06.004

Timeline

Created:June 19, 2026

George N. Pavlakis,

Barbara K. Felber

Article2021

Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques

Article2025

Mesenchymal stromal cell secretome reduces lung injury and thrombo-inflammation induced by SARS-CoV-2 spike protein

Anna Pezzotta, Alessandra Bovio, Barbara Imberti, Monica Locatelli, Daniela Corna, Domenico Cerullo, Sara Gastoldi, Ariela Benigni, Giuseppe Remuzzi, Marina Morigi, Luca Perico

Article2021

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Thrombus Formation

Luca Perico, Marina Morigi, Miriam Galbusera, Anna Pezzotta, Sara Gastoldi, Barbara Imberti, Piero Ruggenenti, Ariela Benigni, Giuseppe Remuzzi

Article2022

SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation

Luca Perico, Marina Morigi, Miriam Galbusera, Anna Pezzotta, Sara Gastoldi, Barbara Imberti, Annalisa Perna, Piero Ruggenenti, Roberta Donadelli, Ariela Benigni, Giuseppe Remuzzi